Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Multiple Sclerosis

  Free Subscription


28.06.2021

1 BMC Neurol
1 J Immunol
1 J Neuroimmunol
3 J Neurol
3 Lancet Neurol
2 Mult Scler
1 Nat Rev Neurol
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Neurol

  1. D'HOOGHE M, Willekens B, Delvaux V, D'haeseleer M, et al
    Sativex(R) (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience.
    BMC Neurol. 2021;21:227.
    PubMed         Abstract available


    J Immunol

  2. CHURCH ME, Ceja G, McGeehan M, Miller MC, et al
    Meningeal B Cell Clusters Correlate with Submeningeal Pathology in a Natural Model of Multiple Sclerosis.
    J Immunol. 2021 Jun 23. pii: jimmunol.2000514. doi: 10.4049/jimmunol.2000514.
    PubMed         Abstract available


    J Neuroimmunol

  3. REYES S, Cunningham AL, Kalincik T, Havrdova EK, et al
    Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement.
    J Neuroimmunol. 2021;357:577627.
    PubMed         Abstract available


    J Neurol

  4. VAN FAALS NL, Dekker I, Balk LJ, Moraal B, et al
    Clinico-radiological dissociation of disease activity in MS patients: frequency and clinical relevance.
    J Neurol. 2020 Jun 20. pii: 10.1007/s00415-020-09991.
    PubMed         Abstract available

  5. BERGMAN J, Burman J, Bergenheim T, Svenningsson A, et al
    Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension.
    J Neurol. 2021;268:651-657.
    PubMed         Abstract available

  6. NIESSEN A, Schwarz B, Urban M, Kramer S, et al
    Aseptic meningitis after glatiramer acetate.
    J Neurol. 2021;268:2589-2590.
    PubMed        


    Lancet Neurol

  7. WIJERATNE T, Grisold W, Baneke P, Helme A, et al
    World Brain Day 2021: a call to stop multiple sclerosis.
    Lancet Neurol. 2021 Jun 21. pii: S1474-4422(21)00200.
    PubMed        

  8. WATTJES MP, Ciccarelli O, Reich DS, Banwell B, et al
    2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis.
    Lancet Neurol. 2021 Jun 14. pii: S1474-4422(21)00095.
    PubMed         Abstract available

  9. THE LANCET NEUROLOGY
    Multiple sclerosis under the spotlight.
    Lancet Neurol. 2021;20:497.
    PubMed        


    Mult Scler

  10. SCHONFELDER K, Schuh H, Pfister F, Kramer J, et al
    Autoimmune glomerulonephritis in a multiple sclerosis patient after cladribine treatment.
    Mult Scler. 2021 Jun 24:13524585211022719. doi: 10.1177/13524585211022719.
    PubMed         Abstract available

  11. ESHAGHI A
    Towards an objective classification of multiple sclerosis.
    Mult Scler. 2021;27:1151-1152.
    PubMed        


    Nat Rev Neurol

  12. MAKHANI N, Tremlett H
    The multiple sclerosis prodrome.
    Nat Rev Neurol. 2021 Jun 21. pii: 10.1038/s41582-021-00519.
    PubMed         Abstract available


    PLoS One

  13. ROGACZEWSKA M, Michalak S, Stopa M
    Macular vessel density differs in multiple sclerosis and neuromyelitis optica spectrum disorder: An optical coherence tomography angiography study.
    PLoS One. 2021;16:e0253417.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: